Funding Opportunities

Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-20-039
Posting Date: October 25, 2019
Expiration Date: September 8, 2022

Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-20-036
Posting Date: October 23, 2019
Expiration Date: September 8, 2022

Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-20-029
Posting Date: October 10, 2019
Closing Date: January 7, 2020; January 7, 2021; January 7, 2022

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01, Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-19-357
Posting Date: September 3, 2019
Expiration Date: January 11, 2022

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21, Clinical Trial Not Allowed) Funding Opportunity Number: PAR-19-364
Posting Date: September 3, 2019
Expiration Date: January 11, 2022

Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PA-19-096
Posting Date: November 29, 2018
Posting Date: January 08, 2022
Closing Date: Standard dates apply, by 5:00 PM local time of applicant organization

New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) Funding Opportunity Number: RFA-AI-20-076
Posting Date: October 20, 2020
Closing Date: August 11, 2022

Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Funding Opportunity Number: RFA-DA-22-033
Posting Date: July 21, 2021
Closing Date: February 17, 2022

Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) Funding Opportunity Number: RFA-DA-23-001
Posting Date: July 9, 2021
Closing Date: August 11, 2022

Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) Funding Opportunity Number: RFA-AI-21-041
Posting Date: July 7, 2021
Closing Date: December 6, 2021

Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) Funding Opportunity Number: RFA-MH-22-106
Posting Date: October 20, 2021
Closing Date: January 07, 2022

HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) Funding Opportunity Number: RFA-CA-21-045, RFA-CA-21-046, RFA-CA-21-047
Posting Date: October 20, 2021
Closing Date: January 07, 2022

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) Funding Opportunity Number: RFA-DA-22-040
Posting Date: September 08, 2021
Closing Date: February 16, 2024

For information about additional funding opportunities please click the relevant link below

For National Institute of Health (NIH):

  • For NIAID click here
  • For NIDA click here
  • For NHLBI click here
  • For NIMH click here

For Centers for Disease Control and Prevention (CDC) Click Here

For Health Resources & Services Administration (HRSA) Click Here